禾元生物-U
(688765)
| 流通市值：28.67亿 | | | 总市值：142.43亿 |
| 流通股本：7197.09万 | | | 总股本：3.58亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 18,274,167.96 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 |
| 营业总成本 | 110,526,540.09 | 50,498,085.64 | 226,004,752.39 | 152,128,298.94 |
| 其他经营收益 | | | | |
| 营业利润 | -64,301,418.86 | -36,083,196.19 | -157,607,699.54 | -121,270,904.18 |
| 利润总额 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 净利润 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -62,756,540.53 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,880,943,890.05 | 1,877,813,174.44 | 2,162,102,820.08 | 240,972,940.91 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,969,642,589.49 | 1,763,419,308.43 | 1,540,785,483.85 | 1,223,055,835.27 |
| 资产总计 | 3,850,586,479.54 | 3,641,232,482.87 | 3,702,888,303.93 | 1,464,028,776.18 |
| 流动负债: | | | | |
| 流动负债合计 | 627,258,046.99 | 566,414,471.62 | 453,597,268.05 | 376,133,296.85 |
| 非流动负债: | | | | |
| 非流动负债合计 | 379,612,708.89 | 206,214,232.88 | 351,400,011.36 | 590,945,076.63 |
| 负债合计 | 1,006,870,755.88 | 772,628,704.5 | 804,997,279.41 | 967,078,373.48 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,843,715,723.66 | 2,868,603,778.37 | 2,897,891,024.52 | 496,950,402.7 |
| 股东权益合计 | 2,843,715,723.66 | 2,868,603,778.37 | 2,897,891,024.52 | 496,950,402.7 |
| 负债和股东权益合计 | 3,850,586,479.54 | 3,641,232,482.87 | 3,702,888,303.93 | 1,464,028,776.18 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 64,395,819.18 | 19,294,559.97 | 154,152,435.22 | 95,436,227.65 |
| 经营活动现金流出小计 | 159,654,036.52 | 68,817,772.56 | 282,471,400.6 | 214,306,122.97 |
| 经营活动产生的现金流量净额 | -95,258,217.34 | -49,523,212.59 | -128,318,965.38 | -118,869,895.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 800,830,000 | 75,000,000 | - | - |
| 投资活动现金流出小计 | 333,715,157.95 | 233,847,042.4 | 1,848,888,635.46 | 331,602,803.67 |
| 投资活动产生的现金流量净额 | 467,114,842.05 | -158,847,042.4 | -1,848,888,635.46 | -331,602,803.67 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 322,299,205 | 24,900,000 | 2,868,495,138.33 | 406,587,096.13 |
| 筹资活动现金流出小计 | 340,670,466.78 | 87,246,814.67 | 382,220,746.24 | 41,676,017.48 |
| 筹资活动产生的现金流量净额 | -18,371,261.78 | -62,346,814.67 | 2,486,274,392.09 | 364,911,078.65 |
| 汇率变动对现金及现金等价物的影响 | -26,615.02 | 239.62 | -27,873.47 | -22,430.7 |
| 现金及现金等价物净增加额 | 353,458,747.91 | -270,716,830.04 | 509,038,917.78 | -85,584,051.04 |
| 期末现金及现金等价物余额 | 1,022,900,000.35 | 398,724,422.4 | 669,441,252.44 | 74,818,283.62 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 353,458,747.91 | - | 509,038,917.78 | - |